Literature DB >> 18216057

New evidence of risk factors for community-acquired pneumonia: a population-based study.

J Almirall1, I Bolíbar, M Serra-Prat, J Roig, I Hospital, E Carandell, M Agustí, P Ayuso, A Estela, A Torres.   

Abstract

The aim of the present study was to identify risk factors for community-acquired pneumonia (CAP), with special emphasis on modifiable risk factors and those applicable to the general population. A population-based, case-control study was conducted, with a target population of 859,033 inhabitants aged >14 yrs. A total of 1,336 patients with confirmed CAP were matched to control subjects by age, sex and primary centre over 1 yr. In the univariate analysis, outstanding risk factors were passive smoking in never-smokers aged >65 yrs, heavy alcohol intake, contact with pets, households with >10 people, contact with children, interventions on the upper airways and poor dental health. Risky treatments included amiodarone, N-acetylcysteine and oral steroids. Influenza and pneumococcal vaccine, and visiting the dentist were protective factors. Multivariable analysis confirmed cigarette smoking, usual contact with children, sudden changes of temperature at work, inhalation therapy (particularly containing steroids and using plastic pear-spacers), oxygen therapy, asthma and chronic bronchitis as independent risk factors. Interventions for reducing community-acquired pneumonia should integrate health habits and lifestyle factors related to household, work and community, together with individual clinical conditions, comorbidities and oral or inhaled regular treatments. Prevention would include vaccination, dental hygiene and avoidance of upper respiratory colonisation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216057     DOI: 10.1183/09031936.00095807

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  108 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  Identification of new risk factors for pneumonia: population-based case-control study.

Authors:  Yana Vinogradova; Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

4.  Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.

Authors:  Filippo Ansaldi; Andrea Orsi; Cecilia Trucchi; Daniela De Florentiis; Antonella Ceravolo; Martina Coppelli; Sergio Schiaffino; Valter Turello; Roberto Rosselli; Roberto Carloni; Giancarlo Icardi; Ligurian Pneumococcal Study Group; Paola Canepa; Laura Sticchi; Roberta Zanetti; Ilaria Cremonesi; PierClaudio Brasesco; Paolo Moscatelli
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.

Authors:  Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

Review 6.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

7.  Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

Authors:  John C Phipps; David M Aronoff; Jeffrey L Curtis; Deepti Goel; Edmund O'Brien; Peter Mancuso
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection.

Authors:  Melissa H Bloodworth; Dawn C Newcomb; Daniel E Dulek; Matthew T Stier; Jacqueline Y Cephus; Jian Zhang; Kasia Goleniewska; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

Authors:  Matthew C Johns; Angelia A Eick; David L Blazes; Seung-eun Lee; Christopher L Perdue; Robert Lipnick; Kelly G Vest; Kevin L Russell; Robert F DeFraites; Jose L Sanchez
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Predictors of health decline in older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.

Authors:  Eduardo Fernandez; Paul Krueger; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-01-04       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.